UCB, Science 37 to conduct virtual clinical trials

UCB S.A. (Euronext:UCB) and Science 37 Inc. (Los Angeles, Calif.) partnered to conduct virtual clinical trials using Science 37's cloud-based, mobile telemedicine platform. Initial studies will focus on neurology and immunology indications.

Science 37 said its "site-less" model offers faster and more diverse recruitment, greater retention of patients and resulting data that is more representative of the real life experience of patients...